Highest-materiality recent filing
Endovia touts federal Schedule III support; CannEpil FDA submission due next week
Federal government voiced support during DEA hearings for moving marijuana to Schedule III; Endovia calls it a policy shift.
Endovia sells 510,951 shares for $107,610 under ELOC with C/M Capital
Issued 510,951 shares to C/M Capital Master Fund, LP for $107,610.62 gross proceeds (~$0.21/share) on Aug 25, 2026.
Endovia (SBEV) hires interim CEO and COO with market-cap bonus incentives
Brady Cobb named Interim CEO, Michael Bondurant Interim COO, effective June 8, 2026.
Endovia achieves first FDA regulatory milestone for CannEpil veterinary program
FDA Center for Veterinary Medicine established INAD File No. 14145 for CannEpil development program.
Splash Beverage Group becomes Endovia Health Sciences; new ticker EDVA on Aug 24
Name change to Endovia Health Sciences, Inc. effective Aug 24, 2026 at 9:30 a.m. ET.
Splash Beverage Q2 loss narrows 64% to ~$4M; rebranding as Endovia Health Sciences
H1 2026 loss from continuing ops ~$4M vs ~$11M in H1 2025, improvement of ~$7M (64%).
Splash Beverage Group to rebrand as Endovia Health Sciences, new ticker EDVA
Name change to Endovia Health Sciences, Inc. effective Aug 24, 2026; new ticker EDVA.
Splash Beverage Group changes name to Endovia Health Sciences, Inc.
Filed Certificate of Amendment on Aug 5, 2026, then a Certificate of Correction on Aug 6 for a scrivener's error.
Collaboration targets companion-animal oncology and chronic pain management; canine applications are initial focus.
Splash Beverage enters development collaboration with Lupvindol for veterinary drug from CannEpil
Lupvindol to lead FDA INAD and conditional approval for CannEpil-based veterinary product in companion-animal oncology and pain.
Splash Beverage expands CannEpil license to veterinary therapeutics; royalty 10% on vet revenue
Expanded exclusive global license for CannEpil to include veterinary applications; royalty 10% of net revenue for vet, 15% for human.
Splash Beverage expands CannEpil license to veterinary applications, targets FDA approval
Expanded exclusive global license for CannEpil to include veterinary therapeutics; royalty 10% of vet net revenue, 15% human.
Splash Beverage extends settlement payments; pays $137,798, owes $137,798 by July 31
Amended settlement agreements with three prior investors; extended payment due dates.
Splash Beverage Group announces 1-for-4 reverse stock split; NYSE American halts trading at $0.0936
Reverse stock split effective July 24, 2026 at 4:30 p.m. ET; authorized shares reduced from 400M to 100M.
Splash Beverage settles $3.3M in liabilities for $550K; approves 1-for-4 reverse stock split
Settled ~$3.3M in legacy accounts payable and accrued liabilities for ~$550K cash; expects ~$2.75M gain on extinguishment.
Splash Beverage settles $2.83M debt for $302K; lender releases all obligations
Outstanding loan balance of $2,834,689 settled for $301,800.55 payment due by Aug 31, 2026.
Splash Beverage sells 9.23M shares for $1.27M under ELOC Agreement
Sold 9,232,047 shares of common stock to C/M Capital Master Fund, LP between June 30 and July 8, 2026.
NYSE American accepted Splash's plan to regain compliance with shareholders' equity requirement under Section 1003(a)(i)-(iii) of the Company Guide.
Exclusive worldwide rights to CannEpil® (CBD/THC) for drug-resistant epilepsy; Licensor gets 15% royalty on net revenue.
Splash Beverage acquires exclusive global rights to CannEpil epilepsy therapy from Argent BioPharma
Exclusive global license for CannEpil, a cannabinoid-based therapy for drug-resistant epilepsy already used in Europe.
Splash Beverage sells 767,953 shares for $117,036 under prior ELOC
Issued 767,953 shares to C/M Capital Master Fund, LP on June 24, 2026 for gross proceeds of $117,036.
Splash Beverage invests CDN$300k in Avicanna for 2M shares and warrants
Completed CDN$300,000 strategic investment in Avicanna Inc. (TSX: AVCN) on June 9, 2026.
Splash Beverage invests $217K in Avicanna, appoints COO, grants options, adopts RSU plan
Invested $217,479 for 2M common shares and 1M warrants of Avicanna Inc. (cannabinoid biopharma).
Splash Beverage Group sells 3.85M shares for $607,720 under ELOC agreement
Issued 3,846,332 shares to C/M Capital Master Fund from May 29 to June 1, 2026.
Splash Beverage submits NYSE compliance plan; LOI with Medterra expired; going concern noted
Submitted compliance plan to NYSE American on May 28, 2026 to address stockholders' equity deficiency; decision pending.
Splash Beverage Group appoints Brady Cobb as Interim CEO; president Meissner resigns
Brady Cobb appointed Interim CEO effective May 9, 2026; he has been a director since Feb 2026.
Splash Beverage receives NYSE delisting notice; shareholders' equity negative $15.3M
NYSE notified Splash on April 29, 2026 that shareholders' equity was ($15.3M) vs. $6M minimum; plan due May 29, 2026.
Splash Beverage appoints Francis Knuettel II to Board, effective April 27
Board appointed Francis Knuettel II as director, effective immediately on April 27, 2026.
Splash Beverage receives $2.8M lender demand; two directors resign
Received demand letter from Decathlon Alpha IV LP for $2,833,395.98 under 2020 loan; disputes default.
Splash Beverage withdraws Series A Preferred Stock designation; no shares outstanding
Filed Certificate of Withdrawal for Series A Preferred Stock with Nevada Secretary of State on April 17, 2026.
Splash Beverage signs LOI to merge with Medterra CBD for enterprise value of $37.6M
Merger would issue ~75.2M shares, including up to 19.99% common stock and two series of convertible preferred.
Splash Beverage signs LOI to merge with Medterra CBD; Medterra generated $52M revenue in FY2025
Non-binding LOI for a business combination with Medterra CBD, a cannabinoid wellness company.
Splash Beverage appoints Brady Cobb to board, advances Splash 2.0 strategy
Board expanded to five directors; Brady Cobb appointed effective Feb 2, 2026.
Splash Beverage sells 145K shares for $98K under ELOC; converts $200K notes into 360K shares
On Jan 27, 2026, sold 145,029 common shares for gross proceeds of $98,170 under ELOC Agreement dated Sep 19, 2025.
Senor Frog's selects Chispo Tequila as house tequila across multiple markets
Chispo Tequila chosen as house tequila at Senor Frog's locations in Florida, Bahamas, and Mexico.
Splash Beverage Group issues $525K promissory note to investor in lieu of equity commitment shares
On January 26, 2026, entered Letter Agreement with C/M Capital Master Fund, LP to replace Commitment Shares (0.5% of ELOC) with a promissory note.
Splash Beverage Group appoints Martin Scott as interim CFO effective Dec 15, 2025
Martin Scott appointed interim CFO (principal financial and accounting officer), effective December 15, 2025.
Splash Beverage terminates $600K options, issues common and Series D convertible preferred
Terminated options to purchase $600,000 of common stock; issued 113,636 common shares and 1,136 Series D shares.
Splash Beverage amends note maturity to Feb 2026; issues $588K senior notes with 15% OID
Borrowed $500,000 from two accredited investors; issued senior promissory notes with aggregate principal amount of $588,235.30 (15% original issue discount).
Splash Beverage CFO resigns, issues $500K senior notes with 15% OID
CFO William Devereux resigns effective November 30, 2025.
Splash Beverage CEO Robert Nistico resigns effective Nov 14, 2025; stays on board
CEO Robert Nistico resigns effective Nov 14, 2025; will remain on Board and work on special projects.
Splash Beverage raises $400K via preferred stock and warrants to accredited investors
Sold 400,000 shares of Series A-1 Preferred and 200,000 warrants for $400,000 gross proceeds on Aug 9 and Oct 24, 2025.
Splash Beverage adopts 2025 equity plan (15% of shares) and amends bylaws
Board approved 2025 Equity Incentive Plan on Sept. 25, 2025, pending shareholder approval.
Splash Beverage Group amends bylaws to clarify stockholder voting and broker non-vote treatment
Adopted October 13, 2025; clarifies that majority of votes entitled to vote constitutes stockholder action.
Splash Beverage Group adopts 2025 equity incentive plan, reduces quorum to 1/3
Board approved 2025 Equity Incentive Plan, subject to shareholder approval; effective until Sept 25, 2035.
Received $2M from two institutional investors via $2.2M OID secured convertible notes due Sept 2026; conversion price lower of $1.75 or $0.01 above closing.
Splash Beverage shareholders approve increase in authorized shares from 7.5M to 400M
At special meeting on Aug 29, 2025, shareholders approved amendment increasing authorized common stock from 7.5M to 400M shares.
Splash Beverage Group regains NYSE American listing compliance; deficiencies resolved
NYSE American confirmed compliance with Sections 1003(a)(i)-(iii) and 1007 of the Company Guide.
Splash Beverage Group warrants (SBEV-WT) to be delisted from NYSE American due to low trading price
NYSE American to delist SBEV-WT warrants for low trading price; trading suspended July 23, 2025.
Splash Beverage exchanges $12.7M debt for preferred equity; buys Costa Rica water rights
Exchanged $12.67M of notes for 126,704 shares of Series B Preferred (stated $100, 12% div, convert at $6.00).
On June 8, 2026, the Board of Directors (the “Board”) of the Company appointed Michael Bondurant, as the Company’s Chief Operating Officer, effective immediately.
On May 9, 2026, Splash Beverage Group, Inc. (the “Company”) appointed Brady Cobb as the Company’s Interim Chief Executive Officer, effective immediately.
On May 12, 2026, William Meissner notified the Company of his resignation as President and all other offices of and employment with the Company, which resignation will become effective on June 1, 2026.
On March 20, 2025, the Board of Directors of Splash Beverage Group, Inc. (the “Company”) appointed Mr. William “Bill” Devereux to serve as Chief Financial Officer of the Company, effective as of the same date.
Simultaneously, the Board of Directors of the Company appointed Mr. Thomas Fore to serve as a Director of the Company, effective March 20, 2025.
On February 7, 2025, Julius Ivancsits resigned as Chief Financial Officer of Splash Beverage Group, Inc.
on February 7, 2025, Dr. John Paglia also notified the Board of his intention to resign as an independent director of the Company and as a member of each committee of the Board on which he served, effective as of March 7, 2025.
Effective April 24, 2024, the Board of Directors of Splash Beverage Group, Inc. (the “Company”) appointed Julius Ivancsits to serve as Chief Financial Officer of the Company.
On March 29, 2024, Stacy McLaughlin resigned as Chief Financial Officer of Splash Beverage Group, Inc. (the “Company”).
On February 26, 2024, the Board of Directors of Splash Beverage Group, Inc. (the “Company”) appointed Dr. John Paglia to serve as a Director of the Company, effective as of the same date.
former Interim Chief Financial Officer, Fatima Dhalla, has resigned as the Interim Chief Financial Officer of the Company , effective January 19, 2024.
On January 24, 2024, the Board of Directors of Splash Beverage Group, Inc. (the “Company”) appointed Ms. Stacy McLaughlin to serve as Chief Financial Officer of the Company, effective as of the same date.
Max materiality 0.85 · Median 0.60 · Most common event other_material